SeyfarthLean consulting unveils Disclosure Dragon software to “jumpstart” crowdfunding offerings (Seyfarth, 25 Feb 2014) – SeyfarthLean Consulting LLC, a subsidiary of law firm Seyfarth Shaw LLP, announced today its Disclosure Dragon software, designed specifically for the crowdfunding industry. Disclosure Dragon is the first advanced document automation solution that helps companies and online portals efficiently and effectively prepare the necessary legal and financial disclosure to conduct crowdfunding offerings. For small businesses and early stage companies, Disclosure Dragon automates, expedites and standardizes the development of a private placement memorandum (PPM) (or other required disclosure documents depending on the type of offering) and supporting exhibits required to satisfy the U.S. Securities & Exchange Commission’s regulations pursuant to the Jumpstart Our Business Startups (JOBS) Act of 2012. Traditionally handled by lawyers, consultants and other advisers, PPM development is typically an expensive and arduous process that proves insurmountable for many small companies. With its advanced user-populated engine, Disclosure Dragon’s interactive and adaptive framework auto-generates a draft PPM at a fraction of the cost and time, guiding users step by step through a detailed series of questions related to their businesses. PPM’s produced by Disclosure Dragon are expected to reduce the time and cost of preparing legal documentation by up to 80%. Importantly, further legal review will be required by the issuer’s counsel to finalize the PPM and is not provided by Disclosure Dragon. Disclosure Dragon will debut on Poliwogg, the leading life sciences funding platform, which expects that many of its funding clients will be attracted to Disclosure Dragon’s time and cost savings, as well as the standardization it provides. For these reasons, one such client, Insero Health, a clinical stage healthcare company developing novel therapeutics for the treatment of epilepsy, is already adopting Disclosure Dragon. This also marks one of first collaborations between Poliwogg and the Epilepsy Foundation, which announced in January their partnership to encourage investment and support for new therapies to help people living with recurrent seizures.
Provided by MIRLN.
Image courtesy of FreeDigitalPhotos.net/Stuart Miles.